Use cases
Who it may plausibly help - and who it won’t magically fix
- NAD+ precursor marketing
- Longevity stacks
If your situation isn’t represented here, that doesn’t prove uselessness - it means our file doesn’t claim a narrow benefit for you without better evidence.
Trials
What the science suggests
Human data quality varies by indication and extract. Registry evidence tier: low. Use the evidence score on this page as a directional read, not a substitute for systematic reviews for your specific question.
Gap analysis
Typical promises vs trial reality
Retail copy for NMN often generalizes mechanisms or pilot outcomes. Compare any “clinically proven” language to primary endpoints, population, and dose.
Calibration
Hype vs reasonable expectations
Marketing and influencer stacks often outpace replicated human outcomes for this category.
Verdict snapshot
Not enough quality human research to justify confident conclusions - treat bold promises skeptically.
Same ingredient, other questions
Focused pages for common searches about NMN (nicotinamide mononucleotide). Each uses the same underlying evidence file with a different lens.
Explore further
A few hand-picked entry points around NMN (nicotinamide mononucleotide): categories, answers to narrow questions, and comparisons.
Related ingredients
Ingredients we group near NMN (nicotinamide mononucleotide) in our model - not interchangeable, but often read together.
- Psyllium husk78/100Strong support
Soluble fiber with strong evidence for constipation and as a lipid adjunct in some guideline discussions when taken with water.
- Omega-3 fatty acids77/100Promising
EPA/DHA support cardiovascular risk reduction contexts in some guidelines; supplements vary widely in quality and dose.
- Prebiotics76/100Strong support
Fibers and oligosaccharides that selectively feed commensal microbes; strongest human stories sit in IBS-style and regularity contexts.
Alternatives
Swaps people discuss alongside NMN (nicotinamide mononucleotide) - still judge each ingredient on its own evidence.